Maxim Yankelevich

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Topics

Peripheral Blood

Immune Response

Top Venues

Journal for immunotherapy of cancer

Case reports in oncological medicine

Cold Spring Harbor molecular case studies

Pediatric hematology and oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Maxim Yankelevich, Archana Thakur, Shakeel Modak, Roland Chu, Jeffrey Taub, Alissa Martin, Dana Schalk, Amy Schienshang, Sarah Whitaker, Katie Rea, Daniel W Lee, Qin Liu, Anthony F Shields, Nai Kong V Cheung, Lawrence G Lum
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells. Journal for immunotherapy of cancer 12 (3) (2024)
Maxim Yankelevich, Archana Thakur, Shakeel Modak, Roland Chu, Jeffrey Taub, Alissa Martin, Dana Schalk, Amy Schienshang, Sarah Whitaker, Katie Rea, Daniel W Lee, Qin Liu, Anthony F Shields, Nai Kong V Cheung, Lawrence G Lum
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells. Journal for immunotherapy of cancer 12 (3) (2024)
Maxim Yankelevich, Archana Thakur, Shakeel Modak, Roland Chu, Jeffrey Taub, Alissa Martin, Dana Schalk, Amy Schienshang, Sarah Whitaker, Katie Rea, Daniel W Lee, Qin Liu, Anthony F Shields, Nai Kong V Cheung, Lawrence G Lum
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells. Journal for immunotherapy of cancer 12 (3) (2024)
Maxim Yankelevich, Archana Thakur, Shakeel Modak, Roland Chu, Jeffrey Taub, Alissa Martin, Dana Schalk, Amy Schienshang, Sarah Whitaker, Katie Rea, Daniel W Lee, Qin Liu, Anthony F Shields, Nai Kong V Cheung, Lawrence G Lum
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells. Journal for immunotherapy of cancer 12 (3) (2024)
Maxim Yankelevich, Archana Thakur, Shakeel Modak, Roland Chu, Jeffrey Taub, Alissa Martin, Dana Schalk, Amy Schienshang, Sarah Whitaker, Katie Rea, Daniel W Lee, Qin Liu, Anthony F Shields, Nai Kong V Cheung, Lawrence G Lum
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells. Journal for immunotherapy of cancer 12 (3) (2024)
Maxim Yankelevich, Archana Thakur, Shakeel Modak, Roland Chu, Jeffrey Taub, Alissa Martin, Dana Schalk, Amy Schienshang, Sarah Whitaker, Katie Rea, Daniel W Lee, Qin Liu, Anthony F Shields, Nai Kong V Cheung, Lawrence G Lum
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells. Journal for immunotherapy of cancer 12 (3) (2024)
Maxim Yankelevich, Jonathan L Finlay, Hamza S Gorsi, William Kupsky, Daniel R Boue, Carl J Koschmann, Chandan Kumar-Sinha, Rajen J Mody
Molecular insights into malignant progression of atypical choroid plexus papilloma. Cold Spring Harbor molecular case studies 7 (1) (2021)
Maxim Yankelevich, David J Hoogstra, Judith Abrams, Roland Chu, Kanta Bhambhani, Jeffrey W Taub
Delayed Granulocyte Colony-Stimulating Factor (G-CSF) Administration after Chemotherapy Reduces Total G-CSF Doses without Affecting Neutrophil Recovery in a Randomized Clinical Study in Children with Solid Tumors. Pediatric hematology and oncology 37 (8) (2020)
Maxim Yankelevich, Sureyya Savasan, Igor Dolgopolov, Roland Chu, George Mentkevich
Small Split Doses of CD34+ Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative Chemotherapy. Case reports in oncological medicine 2017 (2017)